Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedSci Healthcare HoldingsHKSE:02415 -0.65%75 5-Year Yield-on-Cost % is 1.44 as of Sep. 13, 2026, which is 50% above its 10-year median of 0.96. GuruFocus rates HKSE:02415 with a GF Score™ of 75/100 and a GF Value™ of HK$1.43 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 281 Healthcare Providers & Services companies, MedSci Healthcare Holdings ranks worse than 73.31% on this metric.
The historical rank and industry rank for MedSci Healthcare Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:
HKSE:02415'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.81 Med: 0.96 Max: 1.8
Current: 1.44
During the past 6 years, MedSci Healthcare Holdings's highest Yield on Cost was 1.80. The lowest was 0.81. And the median was 0.96.
HKSE:02415's 5-Year Yield-on-Cost % is ranked worse than 73.31% of 281
companies
in the Healthcare Providers & Services industry
Industry Median: 2.96
vs HKSE:02415: 1.44
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
MedSci Healthcare Holdings 5-Year Yield-on-Cost % Related Terms
HKSE:02415 vs VEEV, BTSG, TEM: 5-Year Yield-on-Cost % Comparison
For the Health Information Services subindustry, MedSci Healthcare Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedSci Healthcare Holdings 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedSci Healthcare Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where MedSci Healthcare Holdings's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
MedSci Healthcare Holdings (HKSE:02415) has a 5-Year Yield-on-Cost % of 1.44 as of Sep. 13, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on MedSci Healthcare Holdings and its competitors. This is 50% above median its historical median of 0.96. Over the past decade, MedSci Healthcare Holdings' 5-Year Yield-on-Cost % has ranged from 0.81 to 1.80. According to the industry distribution chart, MedSci Healthcare Holdings ranks #206 out of 281 companies in the Healthcare Providers & Services industry, placing it in the top 73.3%.
Is MedSci Healthcare Holdings' 5-Year Yield-on-Cost % too high?
MedSci Healthcare Holdings' current 5-Year Yield-on-Cost % of 1.44 is 50% above median its 10-year median of 0.96. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 1.80. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.96. MedSci Healthcare Holdings' value of 1.44 is 51.4% below this industry median. Based on the distribution chart, MedSci Healthcare Holdings ranks #206 out of 281 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, MedSci Healthcare Holdings has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MedSci Healthcare Holdings' 5-Year Yield-on-Cost % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedSci Healthcare Holdings ranks #206 out of 281 companies for 5-Year Yield-on-Cost %. This places MedSci Healthcare Holdings in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.96. MedSci Healthcare Holdings' value of 1.44 is 51.4% below this benchmark. Historically, MedSci Healthcare Holdings' own 5-Year Yield-on-Cost % has ranged from 0.81 to 1.80 over the past decade. While the company's 10-year median is 0.96 vs. the industry median of 2.96, MedSci Healthcare Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.96, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedSci Healthcare Holdings's current 5-Year Yield-on-Cost % of 1.44 is 51.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on MedSci Healthcare Holdings and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedSci Healthcare Holdings's current 5-Year Yield-on-Cost % is 1.44, which is 50% above median its own 10-year median of 0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedSci Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, MedSci Healthcare Holdings (HKSE:02415) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.43, compared to a current price of HK$0.76 — trading 46.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.44, which is 50% above median its 10-year median of 0.96 and 51.4% below the Healthcare Providers & Services industry median of 2.96. MedSci Healthcare Holdings' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For MedSci Healthcare Holdings (HKSE:02415), the current 5-Year Yield-on-Cost % is 1.44 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedSci Healthcare Holdings (HKSE:02415) Overvalued in 2026?
Based on GuruFocus' analysis, MedSci Healthcare Holdings stock appears to be undervalued.
The current stock price of HK$0.76 is trading 46.9% below its estimated GF Value™ of HK$1.43.
GuruFocus considers MedSci Healthcare Holdings to be Possible Value Trap.
Key valuation signals for HKSE:02415:
5-Year Yield-on-Cost %: 1.44 (50% above median its 10-year median of 0.96)
GF Value™: HK$1.43 vs. price of HK$0.76 (46.9% below fair value)
Industry Position: 51.4% below the Healthcare Providers & Services median (#206 of 281)
No single metric tells the full story. See the HKSE:02415 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedSci Healthcare Holdings Ltd is an investment holding company. It operates online professional physician platforms in China. The principal activities of the company are the provision of physician platform solutions, precision omni-channel marketing solutions, and real-world study solutions in the People's Republic of China.
75GF Score
Get the complete analysis for HKSE:02415
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02415 has been successfully added to your 
